NSW Health has announced moves to simplify the requirements for prescribers of Schedule 8 (S8) cannabis medicines under the Poisons and Therapeutic Goods Regulation 2008.
Under the amended regulation only Therapeutic Goods Administration (TGA) issued approval will be required in most cases for scripts issued since 30 Sep.
NSW authority will be required for scripts supplying S8 cannabis medicine to children, when extemporaneously compounded for clinical trials, and drug dependent patients.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Oct 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Oct 19
